We've merged with Palleos Healthcare to form a wide-reaching European CRO.
Find out more
Are you an emerging biotech company eager to explore new realms of innovation and seize untapped market opportunities? In today's episode of #IndustryVoice Podcast Series, we are here to provide you with insights on this matter. Join us in this episode to find out about the essential factors to consider when striving for success in the dynamic landscape of modern #bioengineering Our guest, Dr. Liang Zhao, represents #BioEngine, a leading Chinese biotech enterprise specializing in innovative vaccines development and cutting-edge research within the realm of cell and gene therapy.
OCT Clinical is now operating under Palleos Healthcare brand name.
“The merger will undoubtedly create significant synergies, not just doubling but squaring the expertise of both companies”, Philip Räth, Ph.D., managing director at Palleos, said in the release.
“OCT Clinical is proud to join forces with palleos healthcare, as it has an excellent reputation in the industry it serves. Now we can offer tailored solutions to our clients to meet their diverse clinical research needs and accelerate the time of bringing their products to market”, Dmitry Sharov, CEO at OCT Clinical.
